Abstract
The action exerted by estrogens in normal and neoplastic tissues is mainly mediated by the classical estrogen receptors (ER)α and ER. However, recent studies have also indicated that GPR30/GPER mediates rapid effects induced by estrogens through ERK activation and gene transcription. Moreover, GPER overexpression was associated with an aggressive phenotype of estrogen-sensitive tumors, suggesting that the regulation of GPER may be involved in cancer progression. In this context, an EGFR-dependent up-regulation of GPER expression was shown in both ERα-negative and positive cancer cells, providing additional evidence that estrogen and growth factor signaling cooperate in the amplification of mitogenic stimuli in different cell lines. In addition, the physical interaction between either GPER and EGFR or GPER and ERα generated a multi-protein complex, further supporting the functional cross-talk elicited by these receptors in the progression of estrogen-sensitive tumors. Numerous studies have evidenced that the EGFR-mediated transduction pathway contributes to the tamoxifen resistance in patients with breast cancer. As the 4-hydroxytamoxifen binds to and activates GPER, the EGFR-dependent GPER induction observed in tamoxifen-resistant breast cancer cells might be included among the mechanisms involved in the tamoxifen failure in breast malignancy. Surprisingly, an important hallmark of cancer growth, resistance to chemotherapy and decreased survival of patients, such as hypoxia, was demonstrated to regulate GPER expression in breast tumor cells and even in cardiomyocytes. Hence, GPER regulation may be included in the mechanisms leading to the adaptation to hypoxia in cancer and in the cardiovascular system.
Keywords: Estrogen, estrogen receptor, gene expression, G-protein coupled receptor(s), GPR30/GPER, EGF, EGFR, phosphorylation, hypoxia, cancer cells, cardiomyocytes, signal transduction
Related Journals
Related eBooks
Related Articles
-
Aromatase Inhibitors Evolution as Potential Class of Drugs in the Treatment of Postmenopausal Breast Cancer Women
Mini-Reviews in Medicinal Chemistry When BMP Signalling Goes Wrong: The Intracellular and Molecular Mechanisms of BMP Signalling in Cancer
Current Signal Transduction Therapy Ellagic Acid Enhances the Efficacy of PI3K Inhibitor GDC-0941 in Breast Cancer Cells
Current Molecular Medicine Characterization of YY1 OPB Peptide for its Anticancer Activity
Current Cancer Drug Targets Effects of the Natural Isoflavonoid Genistein on Growth, Signaling Pathways and Gene Expression of Matrix Macromolecules by Breast Cancer Cells
Mini-Reviews in Medicinal Chemistry Steroid Sulfatase Inhibitors: Their Potential in the Therapy of Breast Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Selective Estrogen Receptor Modulators. Current and Future Treatment Options for Osteoporosis
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Under Re-organization) To Preliminarily Evaluate The Anticancer Activiy of 1,2-di(quinazolin-4- yl)diselane Against MDA-MB-435 Cells in vitro
Letters in Drug Design & Discovery Targeted Intraoperative Radiotherapy Tumour Bed Boost During Breast Conserving Surgery after Neoadjuvant Chemotherapy in HER2 Positive and Triple Negative Breast Cancer
Reviews on Recent Clinical Trials A Review of Coumarin Derivatives in Pharmacotherapy of Breast Cancer
Current Medicinal Chemistry The Efficacy of Caelyx and Hyperthermia for Anticancer Treatment
Recent Patents on Anti-Cancer Drug Discovery NO to Breast: When, Why and Why Not?
Current Pharmaceutical Design The Role of Antiangiogenetic Agents in the Treatment of Breast Cancer
Current Medicinal Chemistry Novel Nitro-Heterocycles Sugar and Indoles Candidates as Lead Structures Targeting HepG2 and A549 Cancer Cell Lines
Current Bioactive Compounds Mediterrranean Diet and Health Biological Importance of Olive Oil
Current Pharmaceutical Design Interaction of Oligomeric Breast Cancer Resistant Protein (BCRP) with Adjudin: A Male Contraceptive with Anti-Cancer Activity
Current Molecular Pharmacology Malignant Pleural Effusions: Review of Treatment and Our Experience
Reviews on Recent Clinical Trials Clinical Significance of Breast Cancer Resistance Protein/ABCG2 in the Management of Malignancy
Clinical Cancer Drugs Anticancer Vitamin K3 Analogs: A Review
Anti-Cancer Agents in Medicinal Chemistry Understanding Trastuzumab Resistance in HER2 Positive Breast Cancer and Further Therapeutic Options
Current Cancer Therapy Reviews